Analyzing SONOVA Hldg AG/ADR (SONVY) and Its Competitors

SONOVA Hldg AG/ADR (OTCMKTS: SONVY) is one of 46 publicly-traded companies in the “Electromedical equipment” industry, but how does it weigh in compared to its peers? We will compare SONOVA Hldg AG/ADR to similar businesses based on the strength of its analyst recommendations, institutional ownership, dividends, profitability, earnings, valuation and risk.


SONOVA Hldg AG/ADR pays an annual dividend of $0.30 per share and has a dividend yield of 0.9%. SONOVA Hldg AG/ADR pays out 27.8% of its earnings in the form of a dividend. As a group, “Electromedical equipment” companies pay a dividend yield of 1.5% and pay out 38.0% of their earnings in the form of a dividend.

Institutional and Insider Ownership

0.2% of SONOVA Hldg AG/ADR shares are held by institutional investors. Comparatively, 43.5% of shares of all “Electromedical equipment” companies are held by institutional investors. 18.2% of shares of all “Electromedical equipment” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.


This table compares SONOVA Hldg AG/ADR and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
SONOVA Hldg AG/ADR Competitors -169.18% -79.00% -19.73%

Volatility and Risk

SONOVA Hldg AG/ADR has a beta of 0.05, meaning that its stock price is 95% less volatile than the S&P 500. Comparatively, SONOVA Hldg AG/ADR’s peers have a beta of 1.61, meaning that their average stock price is 61% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings for SONOVA Hldg AG/ADR and its peers, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SONOVA Hldg AG/ADR 0 0 0 0 N/A
SONOVA Hldg AG/ADR Competitors 161 479 1011 37 2.55

As a group, “Electromedical equipment” companies have a potential upside of 9.09%. Given SONOVA Hldg AG/ADR’s peers higher possible upside, analysts plainly believe SONOVA Hldg AG/ADR has less favorable growth aspects than its peers.

Valuation and Earnings

This table compares SONOVA Hldg AG/ADR and its peers revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
SONOVA Hldg AG/ADR $2.43 billion $354.51 million 31.74
SONOVA Hldg AG/ADR Competitors $1.11 billion $97.36 million -34.31

SONOVA Hldg AG/ADR has higher revenue and earnings than its peers. SONOVA Hldg AG/ADR is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.


SONOVA Hldg AG/ADR beats its peers on 7 of the 12 factors compared.

SONOVA Hldg AG/ADR Company Profile

Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. It offers hearing instruments, cochlear implants, wireless communication products, and rechargeable hearing aids, as well as professional audiological services. The company provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand name; and professional audiological services under the Connect Hearing brand name. Sonova Holding offers its products through a sales and distribution network, which comprise approximately 50 Sonova-owned wholesale companies and 100 independent distributors; and AudioNova retail network of approximately 3,300 locations in 12 markets. It operates in the Americas, Europe, the Middle East, Africa, and the Asia/Pacific. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.

Receive News & Ratings for SONOVA Hldg AG/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SONOVA Hldg AG/ADR and related companies with's FREE daily email newsletter.

Leave a Reply